NMDAR in bladder smooth muscle is not a pharmacotherapy target for  overactive bladder in mice [PeerJ]

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice [PeerJ]

4.9
(279)
Write Review
More
$ 6.99
Add to Cart
In stock
Description

Figure: Normal Micturition: Coordinated Bladder Contraction and Urethral Sphincter Relaxation - MSD Manual Professional Edition

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice [PeerJ]

Pathophysiological roles and therapeutic potential of voltage-gated ion channels (VGICs) in pain associated with herpesvirus infection, Cell & Bioscience

Pharmacology of the Lower Urinary Tract

OAB Overview Monograph Urovant Medical Affairs

Diabetic bladder dysfunction progresses from an overactive to an underactive phenotype in a type-1 diabetic mouse model (Akita female mouse) and is dependent on NLRP3 - ScienceDirect

Anatomy, Physiology and Pharmacology of the Lower Urinary Tract

Progress in overactive bladder: novel avenues from psychology to clinical opinions [PeerJ]

PDF) The immune responses to different Uropathogens call individual interventions for bladder infection

Transient contractions' in urinary bladder m

Loop Huan Chen

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice [PeerJ]